You are here

Canntab Therapeutics Limited

Canntab Therapeutics Limited
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
PILL
CSE Index: 
Currency: 

Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.

You are here

Canntab Therapeutics Limited (PILL)

SEDAR Information

Company Info

Address
1 Adelaide St. East, Suite 801
Toronto, ON M5C 2V9
Canada
Phone
(647) 209-3279
Email
info@canntab.ca
Website
https://canntab.ca
Listing date
Thursday, April 21, 2011
Transfer Agent
Capital Transfer Agency

Capitalization

Issued & Outstanding: 
38909159
Reserved for Issuance: 
16510036

Bulletins

14/06/2024

2024-0613 - Delist - Canntab Therapeutics Limited (PILL)

le 14 juin/June 2024

The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024.

Canntab Therapeutics is currently suspended. See bulletin 2023-1008.

___________________________